Abstract. Experiments were carried out to examine relationships between alveolar macrophage maturity and amounts of tissue factor (Clotting Factor III) in these cells under physiologic conditions and during immunologically induced pneumonitis. Using discontinuous density gradient centrifugation, alveolar macrophages from healthy rabbits were rapidly isolated into five subpopulations at different stages of maturation, as demonstrated by morphologic and morphometric evaluation. Very large amounts of tissue factor activity were found in fully mature cells that were purified in the lowest density subpopulation and assayed without preliminary in vitro stimulation or culture. In the remaining four subpopulations of increasing density, amounts of tissue factor were found to progressively diminish in direct correlation with declines of cell maturity. These differences at mean levels were as great as 35-fold. In addition, blood monocytes had <1/219 and <1/6 of the activity of the fully mature and the least mature subpopulations, respectively. After 16 h culture of the five isolated subpopulations in the absence oflymphokines or ofsignificant numbers of lymphocytes, tissue factor activity increased in inverse correlation with the preincubation stage ofcell maturity (2,387 and 109% in the least mature and most mature subpopulations, respectively). These increases required protein synthesis and were accompanied by morphologic and morphometric changes which indicated cellular maturation during the period oftissue factor activity generation in vitro, thus further demonstrating relationships between macrophage maturity and tissue factor content. In additional experiments, direct correlations between cell maturity and tissue factor activity content
Introduction
Alveolar macrophages are phagocytic and secretory cells important in pulmonary defense and inflammation (1) (2) (3) . As found in human and animal lungs, these cells have been shown to be heterogeneous with regard to phenotype. The cells are highly variable in enzyme content, oxidative metabolism, bactericidal activity, lysosomal inclusions, surface receptors, cytoplasmic morphology, size, and other properties (4) (5) (6) (7) . This heterogeneity reflects the rapid turnover of the alveolar macrophage, which continuously and randomly enters the lung as a monocyte that matures into macrophages in a few hours. The turnover of alveolar macrophages has been recently calculated to be 5.5 d in the mouse (8) . Phenotypic heterogeneity in these macrophages is augmented after cell exposure to inhaled stimuli, which include bacteria, toxins, and particulate matter, or by systemic stimuli as in Bacillus Calmette Guering (BCG)1 pneumonitis (3, 7) .
In earlier experiments we reported that the alveolar macrophage contains tissue factor. This initiator of the extrinsic pathway ofcoagulation (9) was present in alveolar macrophages at increased levels relative to amounts in several populations oflymphoid cells, especially populations from marrow and blood that contained immature monocyte/macrophage forms (10) . These findings suggested the possibility that macrophages may be heterogeneous with regard to tissue factor content and that levels of this activity may vary according to monocyte/macrophage differentiation or maturation. Therefore, in experiments reported here using animals with BCG pneumonitis and controls, we directly examined relationships between alveolar macrophage maturity and tissue factor as present in vivo and in vitro.
Methods
Alveolar macrophage and blood monocyte isolation. Alveolar macrophages were collected by bronchoalveolar lavage from New Zealand White female rabbits weighing 2-3 kg, as previously described (I 1, 12) . Briefly, the animals were anesthetized by intravenous injection with 3 ml of pentobarbitol, and the lungs were exised and lavaged with 80 ml of sterile saline. The lavaged macrophages were centrifuged, and to lyse any red cells, 10 ml of0.015 M NH4Cl in 0.017 M Tris buffer prewarmed to 370C was added to the cell pellet. The suspended pellet was incubated at 370C for 5 min, washed, and resuspended at 20-40 X 106 leukocytes/ ml in RPMI media containing 25 mM Hepes buffer, 100 U/ml penicillin, and 100 ,g/ml streptomicin. To obtain in vivo activated alveolar macrophages, chronic granulomatous pulmonary reactions were induced by intravenous immunization using 150 Mg of heat-killed BCG suspended in light mineral oil. Animals in the BCG treatment group were sacrificed 21 d after BCG injection. The lungs of these animals, all showing the typical gross pathology of BCG pneumonitis (13), were processed as described above. In experiments using blood monocytes, mononuclear cell populations were isolated from rabbit blood on Ficoll-Hypaque gradients. These populations contained monocytes, lymphocytes, and neutrophils at 20, 80, and <1%, respectively, as previously described (10) .
Washed alveolar macrophage populations obtained by lavage were further purified using centrifugation on discontinuous Percoll gradients (of density 1.055, 1.060, 1.064, 1.068, and 1.070 g/ml). The gradients were made by diluting a stock Percoll solution (nine parts Percoll, one part lOX medium), to 35, 40, 45, Viability was >99% in the remaining four subpopulations. The unfractionated population from BCG-inoculated animals contained 78% macrophages, and the subpopulations, in order of increasing density, contained 85, 93, 89, 79, and 69% macrophages, respectively. Remaining cells were neutrophils and lymphocytes in -2:1 ratios.
Measurements of cell diameters. Morphometric determinations of nuclear and cytoplasmic diameters were made by projecting microscope slides on the surface of a Graf Pen-Gp/3 digitizer (Scientific Accessories Corp., South Port, CT) that was interfaced with a microcomputer (Hewlett-Packard-HP9825S; Hewlett-Packward Co., Calculator Products Div., Loveland, CO). Programs were written for data storage and analysis, and linear measurements were standardized using a marker of known length. Nuclear and cytoplasmic diameters ofcytocentrifuged and stained macrophages from each fraction were measured in duplicate, and results for 200 cells were averaged. Care was taken to randomly select the macrophages counted.
Cell culture. Macrophages from each fraction were incubated in tissue culture grade polypropylene tubes at 1 X 106 cells/ml in 0.5 ml of the medium used for cell isolation, which was supplemented with 10% fetal calfserum. This medium contained <0.005 ng/ml ofendotoxin as determined by Limulus testing. Incubation was for 16 h at 370C in humidified 5% CO2 and 95% air. After incubation, cells were assayed for procoagulant activity. Although we chose to culture macrophages with serum under nonadherent conditions, preliminary studies showed similar effects on in vitro generation of tissue factor under alternative conditions of adherent culture and culture without serum.
Procoagulant activity measurement and characterization. Macrophage procoagulant activity was measured in lysates after a cycle ofcell freezing and thawing. (Amounts of expressed procoagulant activity as measured with viable cells compared with total amounts measured after cell lysis were 61-89% and 69-80% for subpopulations from healthy and BCG animals, respectively. The two highest density fractions from healthy animals were exceptional in that these were found to express as little as 27% of the total activity.) The assays (10) were initiated by adding 0.6 X 101 macrophages in 60 ,l of medium to a clear polystyrene 12 X 75-mm test tube, followed by 60 ,d of 0.025 M calcium chloride and 60 Ml of platelet poor rabbit plasma. Clotting times were determined in duplicate by the manual tilt method and the average of the two measurements was used to calculate procoagulant activity units. Under these conditions, which resembled the nonactivated partial thromboplastin test, contact activation of substrate plasmas during preparation and during the assay is insignificant, as shown by long buffer blank times that were >500's in all of the normal and deficient plasmas used, with or without addition of exogenous lipid in the assay mixture (15, 16) . When added to buffer blanks, the lipids were at 0.02-0.2 nmol P per assay (rabbit brain cephalin, Sigma Chemical Co., St. Louis, MO), which corresponded to dilutions recommended by the manufacturer for an activated partial thromboplastin test. Our methods of standardizing the assay with commercial thromboplastin, of preparing calibration curves, defining TFU, and confirming low intraassay variability (<6% between replicate samples throughout the range of the calibration curve) are the same as previously reported (10) . Tested cells yielded clotting times within the linear portions ofthe calibration curves. The assay consistently detects as little as 1 TFU. Characterization oftissue factor in macrophage subpopulations before and after incubation relied on one-stage assays using human plasmas deficient in single clotting factors and inhibition by Concanavalin A and phospholipase C, as previously reported (10) . For example, one-stage clotting times in assays of the cultured 1.064-g/ml alveolar macrophage subpopulation in substrate plasmas monodeficient in Factors VII, X, II, and V were >370 s. By contrast, clotting times in normal human plasma and in the plasmas deficient in Factor XII, XI, IX, and VIII were much shorter (106-130 s). Since short clotting times were not induced in plasmas deficient in Factors VII, X, II, and V, specific requirements for these factors are shown, and the macrophage procoagulant activity thereby fulfills classic definitions of tissue factor (9, 10) . In the panel of deficient plasmas, brain tissue factor (diluted to shortened clotting times in normal human plasma to the same extent as tested cells) gave differential results identical to those seen with the cells.
Miscellaneous. Protein determinations were made using the Lowry method in diluted samples obtained from cell suspensions immediately after fractionation. Under the conditions ofculture, total cellular protein did not increase detectably by the Lowry assay. Lipid determinations were made by the method of Rouser et al. (17) . Puromycin (Sigma Chemical Co.) added to culture at doses of 1-10 pg/ml had no effect on cell viability or DNA content. Addition of puromycin at 10 pg/ml led to a reduction of total cellular protein by 15-25% compared with totals found after culture without puromycin. Cellular DNA was measured by the diphenylamine method (18) . Data are shown as means±SE of at least three experiments unless otherwise indicated.
Results
Alveolar macrophage isolation as subpopulations of different maturity. To study the relation between alveolar macrophage maturation in vivo and procoagulant activity content, cells freshly obtained by bronchoalveolar lavage were isolated into five subpopulations of different density by centrifugation on discontinuous Percoll gradients. By using morphologic examination, macrophages in the lowest density band (density = 1.055 g/ml) were large cells of mature appearance that had highly vacuolated and granulated cytoplasm. Consistent with the very mature appearance ofthese cells, morphometric studies of this subpopulation demonstrated large overall cytoplasmic diameters and low ratios ofnuclear/cytoplasmic diameters ( Fig.  1) . Morphologically, macrophages in the remaining four macrophage bands of progressively increasing density showed less mature appearance, i.e., they showed decreasing cell size, cytoplasmic granulation, and vacuolation. Concomitantly, morphometric studies showed decreasing cytoplasmic diameters and increasing nuclear/cytoplasmic ratios, which confirmed the stepwise declines of macrophage maturity as cell density increased from the 1.055 to the 1.070 g/ml band (Fig. 1) . Mac Cell Density (g/ml) Figure 1 . Alveolar macrophages were isolated using discontinuous Percoll gradients of densities indicated on the abscissa. Nuclear and cytoplasmic diameters were determined by morphometric techniques described in Methods. Nuclear/cytoplasmic ratios were calculated from mean diameters measured in experiments with four animals.
activity became progressively smaller with declining cell maturity (Table I) . When calculated as TFUI/106macrophages, differences between mean amounts of procoagulant activity in subpopulations of different maturity were found to be as great as 35- fold, as seen by comparing results for the most and least dense cell bands (Table I) . Furthermore, even the least mature subpopulation had more procoagulant activity than blood mono- (Table I) . As compared with monocytes, the most and least mature macrophage subpopulations had >219-and >6.2-fold higher mean procoagulant activities, respectively. Total macrophage lipid and protein concentrations and normalization ofprocoagulant activity relative to these constituents. Macrophage lipid content in the subpopulations showed progressive decreases from the least dense band (1.055 g/ml) to the most dense band (1.070 g/ml) (Table II) . Thus, like TFU, lipid content was directly correlated with subpopulation maturity. Normalization of TFU per nmol P (total cellular lipids) rather than cell number showed that gains of tissue factor activity in the more mature alveolar macrophages outpaced the lipid increases accompanying maturation and enlargement (Table II) . Total macrophage protein and DNA content did not vary appreciably from one band to the other. Results obtained after normalization of TFU for cell protein are shown (Table II) .
Changes of alveolar macrophage procoagulant activity in vitro: inverse correlation between percentage increases oftissue factor and stage ofmaturity before cellular incubation. The five subpopulations of macrophages were incubated as suspension cultures in vitro for 16 h and procoagulant activity was then measured. All showed increases of tissue factor as compared with preincubation (0 h) levels (Table III) . These increases were inversely correlated with the stage ofcell maturity. For example, the least mature subpopulation increased in procoagulant activity by 2,387% after incubation, as contrasted with only a 109% increase in the most mature subpopulation (see the 1.055 and 1.070 g/ml fractions, respectively, Table III ). During incubation, macrophage diameters increased and nuclear/cytoplasmic ratios decreased (Table IV) , which demonstrated that gains in procoagulant activity in vitro were concomitant with these changes characteristic of cellular maturation. The procoagulant activity generated in vitro by each subpopulation was identified as tissue factor using methods similar to those used for freshly isolated cells. Since lymphocytes were absent from the subpopulations (<2% of the isolated cells), these in vitro procoagulant activity increases in the alveolar macrophage subpopulations were independent of direct lymphocyte-macrophage interaction. Addition of 10 ug/ml of puromycin to the cultures inhibited the increases in tissue factor in all subpopulations to 4% of control values, which indicated a requirement for protein synthesis. Procoagulant activity ofalveolar macrophagesfrom animals with BCG pneumonitis. Procoagulant activity in alveolar macrophages lavaged from rabbits with BCG-induced granulomatous pneumonitis was investigated using methods similar to those used for the studies of healthy animals. Again, macrophage tissue factor levels correlated directly with cell maturity. Activity was highest in the least dense subpopulation and progressive declines were seen as subpopulation density increased (Table  V) . Quantitative comparison of TFU (Tables I and V) showed that the low density subpopulation of macrophages from BCGinoculated rabbits had less (4.8-fold) tissue factor per cell than the same density fraction from the control animals. Remaining subpopulations from the two groups had nearly equivalent activity per 1 X 106 cells (see Tables I and V) . For BCG animals the total numbers of macrophages recovered were increased by 6. 1-fold (Tables I and V) . Contrasting with the predominance of high density/relatively immature macrophages found in normal populations, the majority ofcells isolated from BCG animals were in low density/more mature subpopulations (Fig. 2) . Total amounts of macrophage tissue factor recovered from the BCG animals were 11 .2-fold greater than amounts found under control conditions (see Tables I and V) .
Discussion
The present experiments examine relationships between alveolar macrophage maturation and tissue factor activity. Five subpopulations of macrophages, each at a different stage of mat- uration, were isolated using bronchoalveolar lavage techniques followed by centrifugation on discontinuous density gradients. In the five cell subpopulations obtained from healthy animals and assayed for procoagulant activity without prior in vitro culture or stimulation, the stage of cell maturity as determined by morphologic and morphometric criteria correlated directly with tissue factor levels. Thus, alveolar macrophages characterized as fully mature were found to have very high levels of tissue factor activity, and progressively less mature cells in the remaining four subpopulations had proportionally smaller amounts. In these populations, cells with advanced maturity and high activity comprised only a minor component of the total macrophages isolated, and less mature cells with relatively small amounts of tissue factor predominated in number. Consistent with observations relating tissue factor levels to maturation, even the least mature of the five subpopulations studied was found to have more tissue factor activity than blood monocytes, which are cells considered to be precursors of alveolar macrophages (8, 19) .
The subpopulations isolated from healthy control animals were subsequently incubated in vitro to compare potential for production of additional procoagulant activity. During incubation, tissue factor activity was observed to increase by amounts that were inversely correlated with the degree of maturity of each subpopulation. Thus, subpopulations that were relatively immature at the onset of incubation showed the greatest percentage increases. Maturation, defined by morphologic and morphometric criteria, was shown to occur in the immature cells during the incubation period, which again indicated the relationship of macrophage maturity to tissue factor levels.
Of further interest is the finding that lymphocytes were not required for the in vitro tissue factor activity increases seen, since lymphocytes comprised <2% of the cells isolated in our experiments with control animals used for these studies. More-over, subpopulations isolated from some animals were completely devoid of lymphocytes. This demonstration of lymphocyte-independent procoagulant activity increases, which at mean levels were as great as 2,387%, differs from reports describing lymphocyte or lymphokine requirements for significant in vitro procoagulant activity generation by murine and human cells of macrophage lineage obtained from blood, peritoneum, spleen, and cell line sources (20) (21) (22) (23) (24) (25) (26) . Although tissue factor increases in incubated alveolar macrophages were independent of added lymphocytes or lymphokines, it is possible that critical interactions with accessory cells or products of such cells occurred in the complex environment of the lung before macrophage isolation.
To examine effects of in vivo macrophage activation on tissue factor activity, experiments were carried out using animals with chronic granulomatous pneumonitis that was induced with heat-killed BCG (13) . Alveolar macrophages from animals with this type of immune pulmonary reaction consistently differ from normal controls with respect to oxygen consumption, enzyme content, number and affinity of complement and Fc receptors, and other markers considered to indicate a state ofcell activation, as shown by previous experience in our laboratory and by other investigators (13, 27-29, for a review see reference 1). Our present findings with these activated macrophages closely resembled results obtained with healthy animals, in that tissue factor levels as assayed using freshly isolated subpopulations directly correlated with stages of cell maturity. However, as compared with controls, total amounts of alveolar macrophage tissue factor were found to be greatly increased. This was in part due to recovery of more cells than from controls, a finding likely explained by the characteristic accumulation of alveolar macrophages in BCG granulomatous pneumonitis (13) . Further, the tissue factor increases in this model of chronic immunologic pulmonary inflammation were also a result of an intrapopulation shift to mature macrophage forms that have relatively high levels of the procoagulant.
The possibility that macrophage tissue factor levels might be related to cell maturity was suggested to us by our earlier experiments (10) . These studies showed that tissue factor activity is present in different amounts in lymphoid populations isolated from six distinct anatomic sites. Differences of activity were found to be especially great in comparing alveolar macrophages with blood and marrow cells, populations which contain alveolar macrophage precursors. Another finding was that, in marrow and blood populations, tissue factor increased in vitro by far greater percentages than in alveolar macrophages, which suggests that relatively immature cells might have the largest potential for producing additional activity (30) . However, from these earlier studies it was not possible to conclusively determine whether tissue factor activity was related to cell maturation, since the investigated lymphoid populations contained monocytes/macrophages of varying maturity as well as leukocytes of other classes. In another series of earlier experiments we found increased tissue factor activity in monocytes/macrophages isolated from rejected canine kidney allografts relative to amounts in precursors of these cells from blood (31) . The very limited numbers of monocytes/macrophages obtained from these kidney grafts precluded subfractionation experiments for quantitation of intrapopulation heterogeneity with regard to parameters of cell maturation and tissue factor content.
To overcome difficulties encountered in studies comparing populations containing mixed classes and/or limited numbers of cells, we studied, in the experiments described here, the effects of maturation using alveolar macrophages. As obtained from control animals, this is a highly purified population of~-90 X 106 cells that did not require depletion steps to remove lymphocytes or other cell types. The Percoll fractionation technique selected for separation of these macrophages into subpopulations of different maturities has the advantages of being rapid and relatively atraumatic. In addition, cellular incubation under conditions that might induce generation of procoagulant activity in vitro are avoided during the procedure. In view of the conditions used for obtaining alveolar macrophages and earlier work showing that several hours of in vitro culture are needed for production of leukocyte procoagulants (21) (22) (23) 32) , it is likely that tissue factor levels, as measured here in these unincubated cells, are representative of amounts present in vivo.
Criteria for advanced cell maturity in the present studies included findings of a large cytoplasmic diameter and a low ratio of nuclear-cytoplasmic diameters. These criteria were adopted because ofthe general agreement that during monocyte/ macrophage maturation in vivo and in vitro there is overall cell enlargement that mainly results from cytoplasmic rather than nuclear growth (7, 33, 34) . Measurements of diameters were carried out by tracing cell dimensions, using optically projected stained smears for image enlargement and a light pen digitizer with output to a computer. This methodology provided resolution of cell size differences in the range required for discriminating the macrophage subpopulations. In evaluating maturity we also included comparisons of cytoplasmic granulation and vacuolation, since it is well known that these readily detectable morphologic features become increasingly prominent during monocyte/macrophage maturation (33, 34) .
Total cell lipids were studied as an additional marker of maturation, since alveolar macrophage lipids increase as these cells phagocytose surfactant in the alveolar space (3, 35) . Indeed, in the present studies we found that lipid content correlated directly with the degree of alveolar macrophage maturation. By contrast, total cell protein content did not change appreciably at the various stages of maturation examined. In comparing indices of maturation in the alveolar macrophage, it was of interest to find that differences in amounts of tissue factor activity in the subpopulations studied were very pronounced in proportion to changes in other parameters including total cell lipids, protein, DNA, density, and cytoplasmic or nuclear/cytoplasmic diameters.
Subpopulations of mature alveolar macrophages found to have the largest amounts of tissue factor are not necessarily cells that also express maximum levels of classical metabolic or functional activation markers. Indeed, available studies using rabbit alveolar macrophages that are subfractionated by density show that several activation markers are maximal in high or intermediate rather than low density fully mature cells. These markers include hexose monophosphate shunt utilization, phagocytosis, and content of fi-glucuronidase, acid protease, neutral protease, and acid phosphatase (4, 36 ). An exception is nitroblue tetrazolium reduction, which is greatest in fully mature alveolar macrophages (4). Thus, in alveolar macrophages not all activation markers peak at the same stage of maturation, which is a finding consistent with current information about the heterogeneity ofmacrophages from sources outside the lung (37, 38). Whether induction of tissue factor in the lung environment occurs at specific stages of the cell cycle together with characteristic types of metabolic or functional activation is unknown. It is possible that this induction occurs as a discrete event or repetitively at different times during the macrophage lifespan in response to activation by ambient stimuli such as the aerobic environment, inhaled particulate matter, and microbes in the airway. Either discrete or repetitive activation would be consistent with the present finding that isolated immature and mature forms of alveolar macrophages are capable of generating additional tissue factor.
The precise physiologic role oftissue factor activity in alveolar macrophages remains to be determined. However, from the present experiments, it is clear that tissue factor activity becomes available in progressively inraed amounts in these cells during maturation from blood monocytes and immature alveolar macrophage forms. Thus, tissue factor is a marker of alveolar macrophage maturation in vivo. Low levels of tissue factor activity as found in blood monocytes and in precursors ofalveolar macrophages would seem to be a property which allows circulation ofthese cells without thrombosis, since increases of this activity in monocytes may trigger intravascular coagulation, as observed during endotoxemia and menningococcemia (10, 39, 40) . The higher levels of the activity, as found in maturing alveolar macrophages, cells with limited physiologic potential for interaction with the clotting system in blood due to extravascular localization, suggest an adaptation for protective functions in the event of capillary injury and extravasation of blood. Indeed, from current evidence it appears that in a variety ofdisases, producing pulmonary capillary injury, plasma coagulation proteins leak into the alveolar space where alveolar macrophages are localized, and that this type ofinjury can be associated with coagulopathies and fibrin deposition on alveolar membranes (41, 42). The increases of tissue factor activity demonstrated here in cell populations from animals with granulomatous hypersensitivity pneumonitis show that this activator of the extrinsic coagulation pathway can be induced in vivo by immune pulmonary reactions that effect alveolar macrophage accumulation and maturation. These increases suggest that alveolar macrophage tissue factor may contribute to the fibrin deposition, which is found in immune lung diseases such as tuberculosis and allergic alveolitis and in experimental models of delayed hypersensitivity (43) (44) (45) (46) .
